Pharm-Olam operates three Centers of Excellence (COEs) which have been built to provide an ecosystem of cross-functional, therapeutically aligned teams supported by aligned sites and vendors. In addition, Pharm-Olam supports additional therapeutic areas under its General Medicine banner. With coverage in 60+ countries, we're therapeutically and geographically positioned to support your study needs.
Rare disease CRO services with more than 100 rare and orphan disease clinical trials completed, we provide the expertise and experience to meet the unique challenges of these studies.
Infectious disease and vaccine CRO services with global site networks, expeditionary capability and deep expertise with government funded research. Prepared to support every area from immunizations to immunotherapy.
Our dedicated team of cancer researchers create solutions and provide consultations focused on the needs of your sites and patients — all while helping to save your study time and money.
We provide diverse therapeutic expertise in areas such as allergy-respiratory, gastroenterology, neurology-pain, and rheumatology and inflammation to ensure all the moving parts of your study function seamlessly.
March was Rare Disease Month at Pharm-Olam. We started off by reviewing an article that was...
Learn about Pharm-Olam was contracted to manage and recruit four sites for Phase I, first-in-human research of a PD-1 drug treatment for solid tumor malignancies.
June 8, 2020 – June 11, 2020
San Diego, CA
